Literature DB >> 26916923

Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.

Hossein Danafar1,2, Ali Sharafi3, Hamidreza Kheiri Manjili4, Sina Andalib5.   

Abstract

PURPOSE: Among the potent anticancer agents, d,l-sulforaphane (SF) is very effective against many different types of cancer cells. Its clinical application is restricted because of its hydrophobicity, low gastrointestinal absorption and poor bioavailability. In the present study, a reliable micellar delivery system using monomethoxypoly (ethylene glycol)-poly (ɛ-caprolactone) (mPEG-PCL) was established. The encapsulation of SF inside mPEG-PCL as a nano-carrier was established and the cytotoxicity assay against human breast cancer cell line was evaluated.
METHODS: In this study, SF was encapsulated within mPEG-PCL micelles through a single-step nano-precipitation method, leading to creation of SF-loaded mPEG-PCL (SF/mPEG-PCL) micelles. Di-block mPEG-PCL copolymers were synthesized and used to prepare micelles. MPEG-PCL copolymer was characterized by HNMR, FTIR, differential scanning calorimetry and gel permeation chromatography techniques. Characterization, stability of micelles, the particle size and morphology were determined. The release profile of the SF from the micelles which prepared by the drug-loaded copolymer, was evaluated. The cytotoxicity of free SF, mPEG-PCL and SF-loaded mPEG-PCL micelles was compared with each other by performing MTT assay of the treated MCF-7 cell line. Expression levels of BCL-2, MMP-9, BCL-XL, BAK, BAX and GAPDH (endogenous gene) as control were quantified by real time PCR. To evaluate the apoptotic effects of Free SF compared with SF-loaded mPEG-PCL micelles, flow cytometry analysis was done using the annexin V-FITC apoptosis detection kit.
RESULTS: Our studies resulted in a successful establishment of uniformity and spherical SF-loaded mPEG-PCL micelles. The encapsulation efficiency of SF was 86 ± 1.58%. The results of atomic force microscopy revealed that the micelles have spherical shapes with size of 107 nm. In vitro release of SF from SF-entrapped micelles was remarkably sustained. The mPEG-PCL micelle showed little cytotoxicity in the case of MCF-7 cell line with concentration up to 1.5 mg/ml, whereas the SF-loaded mPEG-PCL micelles at all concentrations significantly was cytotoxic in the case of MCF-7 cell line. Finally, real-time PCR and flow cytometry were used to demonstrate that the SF-loaded mPEG-PCL could be efficiently inducing apoptosis in MCF-7 cell line.
CONCLUSION: We achieved to a successful formulation of SF-loaded m-PEG/PCL micelles in this study. Based on the cytotoxicity results of mPEG-PCL micelles against human breast cancer cell line (MCF-7) in this study, it suggested that SF/mPEG-PCL micelles can be an effective breast cancer treatment strategy in the future.

Entities:  

Keywords:  PCL; d,l-Sulforaphane; drug delivery; mPEG; micelles

Mesh:

Substances:

Year:  2016        PMID: 26916923     DOI: 10.3109/10837450.2016.1146296

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  13 in total

1.  Preparation and Characterization of Hyaluronic Acid-Polycaprolactone Copolymer Micelles for the Drug Delivery of Radioactive Iodine-131 Labeled Lipiodol.

Authors:  Shih-Cheng Chen; Ming-Hui Yang; Tze-Wen Chung; Ting-Syuan Jhuang; Jean-Dean Yang; Ko-Chin Chen; Wan-Jou Chen; Ying-Fong Huang; Shiang-Bin Jong; Wan-Chi Tsai; Po-Chiao Lin; Yu-Chang Tyan
Journal:  Biomed Res Int       Date:  2017-01-03       Impact factor: 3.411

2.  Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.

Authors:  Jinsong Liu; Youyun Zeng; Shuai Shi; Lihua Xu; Hualin Zhang; Janak L Pathak; Yihuai Pan
Journal:  Int J Nanomedicine       Date:  2017-05-08

Review 3.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

4.  Co -delivery of Sulforaphane and Curcumin with PEGylated Iron Oxide-Gold Core Shell Nanoparticles for Delivery to Breast Cancer Cell Line.

Authors:  Hossein Danafar; Ali Sharafi; Shaghayegh Kheiri; Hamidreza Kheiri Manjili
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

5.  Preparation, characterisation, and controlled release of sex pheromone-loaded MPEG-PCL diblock copolymer micelles for Spodoptera litura (Lepidoptera: Noctuidae).

Authors:  Yixin Chen; Xiuqin Chen; Yong Chen; Hui Wei; Shuo Lin; Houjun Tian; Tao Lin; Jianwei Zhao; Xiaojun Gu
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

Review 6.  The Glucosinolates: A Sulphur Glucoside Family of Mustard Anti-Tumour and Antimicrobial Phytochemicals of Potential Therapeutic Application.

Authors:  James Melrose
Journal:  Biomedicines       Date:  2019-08-19

Review 7.  Insights about stabilization of sulforaphane through microencapsulation.

Authors:  Víctor Zambrano; Rubén Bustos; Andrea Mahn
Journal:  Heliyon       Date:  2019-11-28

8.  Optimization and Pharmacokinetic Evaluation of Synergistic Fenbendazole and Rapamycin Co-Encapsulated in Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles.

Authors:  Hee Ji Shin; Min Jeong Jo; Ik Sup Jin; Chun-Woong Park; Jin-Seok Kim; Dae Hwan Shin
Journal:  Int J Nanomedicine       Date:  2021-07-16

9.  The Influence of Red Cabbage Extract Nanoencapsulated with Brassica Plasma Membrane Vesicles on the Gut Microbiome of Obese Volunteers.

Authors:  Paula Garcia-Ibañez; Carles Roses; Agatha Agudelo; Fermin I Milagro; Ana M Barceló; Blanca Viadel; Juan Antonio Nieto; Diego A Moreno; Micaela Carvajal
Journal:  Foods       Date:  2021-05-10

10.  Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy.

Authors:  Yuzhu Hu; Yihong He; Jianrui Ji; Songping Zheng; Yongzhong Cheng
Journal:  Int J Nanomedicine       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.